by Peter | Apr 7, 2024 | Events, News, Prostate Cancer, Uncategorized
Skip to Main Content Log in COMMENT| VOLUME 378, ISSUE 9809, P2056-2057, DECEMBER 17, 2011 Download Full Issue High-risk prostate cancer: treat the prostate Matthew R Cooperberg Published:November 03, 2011DOI:https://doi.org/10.1016/S0140-6736(11)61254-3 PlumX Metrics...
by Peter | Aug 13, 2021 | News
mpMRI Misses Few Significant Prostate Cancers in Re-Biopsied Men Obesity Linked to Lower Death Risk in mCRPC EAU 2021: De Novo Versus Recurrent Metastatic mHSPC: What Is the Role of Modern Imaging? EAU 2021: Phase 3 Study of 177Lu-PSMA-617 in Patients with Metastatic...
by Peter | Apr 4, 2021 | News
News & Information from Us Too While we all must remain safe and socially distant due to COVID-19 restrictions, it is important for everyone to continue to monitor and address their health concerns, and stay connected to others. Us TOO has virtual prostate cancer...
by Peter | Sep 20, 2019 | News, Prostate Cancer
Members of the Board of Directors for the NH Prostate Cancer Coalition meet with NH Governor Chris Sununu to receive a Proclamation declaring September as Prostate Cancer Awareness Month.
by Peter | Sep 18, 2019 | Events, News
September 18, 2019 – Last night the U.S. Food and Drug Administration (FDA) approved apalutamide (Erleada) for the treatment of metastatic hormone-sensitive (aka, “castration-sensitive”) prostate cancer (mHSPC). Apalutamide has previously received FDA-approval for the...
